LAS VEGAS, Nov. 23 /PRNewswire-FirstCall/ -- Cord Blood America, Inc. (OTC Bulletin Board: CBAI), the umbilical cord blood stem cell preservation company (http://www.cordblood-america.com) focused on bringing the life saving potential of stem cells, a biological insurance policy, to families nationwide and internationally, announced today that an updated progress interview with CEO and co-founder Matthew Schissler is now available.
The entire interview is at: http://blip.tv/file/2875811 .
In the interview, Mr. Schissler updates progress at the Company's laboratory in Las Vegas, answers questions asked on the Company's "Facebook" fan page, and shows off the new facility for investors to view.
"My message is: 2010 will focus on top-line revenue growth including organic growth, acquisitions, and diversifying the revenue streams," Cord Blood America's CEO said.
About Cord Blood America
Cord Blood America (OTC Bulletin Board: CBAI) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTC Bulletin Board: CBAI), visit our website at www.corcell.com. For investor information, visit http://www.cordblood-america.com.
CONTACT:
Paul Knopick
E & E Communications
949/707-5365
pknopick@eandecommunications.com
SOURCE Cord Blood America, Inc.
